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Myocardial ischemia results from an imbalance between
oxygen supply and demand. After coronary occlusion, oxy-
gen supply and demand mismatch produces a series of
physiological alterations that can precede clinical symptoms
(1). Impaired myocardial perfusion is an early event in the
“ischemic cascade” that can be assessed using clinically
available noninvasive imaging. Both extent and severity of
perfusion deficits have been shown to predict longitudinal
clinical outcomes, including cardiovascular mortality risk
(2). Accordingly, current American College of Cardiology/
American Heart Association guidelines support of stress
perfusion imaging for assessment of symptomatic patients
with intermediate or high pre-test likelihood of coronary
artery disease (CAD) (3).
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Although important information can be gained from
myocardial perfusion imaging, this approach evaluates only
a single aspect of the ischemic cascade. Although perfusion
assesses oxygen supply, it does not evaluate myocardial
oxygen demand and, is therefore, an incomplete index of
ischemic physiology. Animal studies using direct coronary
blood sampling have demonstrated that oxygen consump-
tion is reduced in the setting of myocardial hibernation (4),
a condition in which contractile function is down-regulated
in parallel with chronic hypoperfusion. The importance of
myocardial oxygen consumption has also been demonstrated
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disclose.using positron emission tomography (PET) based 11C-
acetate imaging. Among patients with obstructive CAD,
preserved myocardial oxidative metabolism on PET has
been shown to differentiate viable from nonviable myocar-
dium, and this approach has performed favorably for pre-
diction of functional response to revascularization compared
with other PET methods such as assessment of glucose
metabolism (5,6). Oxygen supply and demand can also be
independent of one another. For example, in the context of
acute myocardial infarction, delayed revascularization can
restore coronary blood supply to transmurally infarcted
myocardium in which cellular metabolism is minimal (7),
potentially leading to a scenario in which perfusion is
normal, but oxygen consumption is negligible. Taken to-
gether, these concepts illustrate that oxygen supply and
demand can individually vary in response to physiological
stimuli, resulting in differing magnitudes of myocardial
ischemia that may not be fully discernable via assessment of
perfusion alone.
Cardiac magnetic resonance (CMR) imaging holds the
potential to assess both myocardial perfusion and oxygen
consumption. Unlike PET, CMR does not entail exposure
to ionizing radiation, and is thereby well suited to assess
temporal changes in cardiac physiology. Perfusion can be
assessed based on regional signal intensity differences during
first-pass infusion of gadolinium-based contrast agents.
CMR stress perfusion imaging is an established clinical
technique that has been shown to yield favorable diagnostic
performance for obstructive CAD compared with other
modalities (8,9). Independent of perfusion, CMR can assess
myocardial oxygenation consumption via a technique
termed blood oxygen level–dependent (BOLD) imaging.
This technique, which can be performed without contrast
administration, is predicated on differences in magnetic
susceptibility between oxyhemoglobin and deoxyhemoglo-
bin. Whereas oxyhemoglobin is mildly diagmagnetic, de-
oxyhemoglobin is paramagnetic, and this latter property
produces local field gradients between red blood cells and
their surroundings. The shift in frequency caused by these
gradients affects transverse (T2) relaxation times, with red
blood cell deoxygenation (deoxyhemoglobin) causing T2 to
decrease. BOLD imaging exploits T2 differences between
oxyhemoglobin and deoxyhemoglobin, and thus provides a
measure of myocardial oxygen consumption. Like perfusion,
BOLD imaging can be performed during rest and pharma-
cological stress conditions to assess dynamic changes in
myocardial physiology. BOLD imaging has been validated
in animal models and has been shown to be feasible in
human studies (10–12). However, clinical application has
been limited, possibly due to variable image quality yielded
by conventional pulse sequences for BOLD assessment.
In this issue of the Journal, Arnold et al. (13) evaluate
clinical application of BOLD imaging for detection of
CAD. To optimize BOLD image quality, the investigators
utilized high field strength (3-T) CMR and applied a
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BOLD New Directions in Myocardial Ischemia Imaging May 29, 2012:1965–7recently developed approach, whereby data was acquired
using a T2-prepared, steady-state free precession pulse
sequence sampled across multiple RR intervals. Both
BOLD and perfusion CMR imaging were performed at
baseline and during adenosine stress, with results analyzed
quantitatively. Diagnostic performance of BOLD imaging
for obstructive CAD was compared with perfusion CMR
among patients who underwent invasive angiography. Myo-
cardial oxygen consumption, as manifest on BOLD, was
also examined in relation to clinical indexes as well as
conventional CMR findings (i.e., perfusion, hyperenhance-
ment) to assess whether oxygen consumption varies in
relation to physiological substrate. Regarding diagnostic
performance, results demonstrated that BOLD yielded
slightly lower accuracy (86%) than did perfusion CMR
(91%), with differences between the 2 techniques attribut-
able to lower specificity for BOLD (72%) compared with
perfusion (89%). Additionally, whereas this study found
that the likelihood of an abnormal BOLD response gener-
ally declined as perfusion-evidenced hyperemic blood flow
increased, the 2 indexes correlated weakly (r  0.26), as
videnced by the fact that half of hypoperfused segments
emonstrated no evidence of deoxygenation.
Based on current results, is BOLD imaging ready for
idespread clinical application to test for CAD? Further
ncorporation of physiological indexes is certainly attractive
s a potential means of better characterizing ischemic
urden. However, although findings from this comprehen-
ive study are encouraging, several issues are worth consid-
ring. First, despite application of a sophisticated BOLD
echnique to a population at increased likelihood for CAD
i.e., all patients undergoing x-ray angiography had symp-
omatic chest pain clinically deemed to warrant further
valuation via invasive testing), BOLD yielded a 2-fold
igher false positive rate (12%) than did perfusion imaging
5%). Although it is plausible that this may reflect subtle
hanges in myocardial oxygen consumption that occur in
he absence of perfusion-evidenced deficits or angiography-
videnced coronary obstruction, an alternative possibility is
hat current generation BOLD techniques remain compro-
ised by low signal intensity and/or image artifacts that
imic physiological abnormalities. Additionally, BOLD
maging as applied in this study was limited to a single
hort-axis slice. This approach is suboptimal for assessment
f global ischemia and distal CAD, emphasizing the need
or novel technical approaches that can improve BOLD
patial coverage without compromising signal-to-noise or
verall image quality. Three-dimensional data acquisition
ith navigator-based respiratory motion compensation (to
liminate breath-holding) could potentially be used to
mprove BOLD spatial coverage (12).
More broadly, although the current study provides a
aluable comparison of BOLD to state-of-the-art CMR
erfusion, it is important to recognize that clinical stress
MR protocols typically integrate perfusion data with ateast 2 additional components—systolic function and infarct iassessment. A strategy of integrated stress CMR interpre-
tation has previously been shown to improve test perfor-
mance for CAD (14), and a similar interpretive approach
has been used in multicenter studies (9). In the context of
the previously noted false positive rates in this study, it is
unlikely that current generation BOLD techniques are
ready to replace perfusion as a first-line approach to identify
obstructive CAD. Although the investigators also report
novel findings concerning BOLD in the context of nonob-
structive CAD, the clinical implications of such imaging
findings are uncertain. Thus, an outstanding question con-
cerns whether BOLD imaging incrementally improves di-
agnostic test performance or prognostic assessment above
and beyond integrated perfusion/infarction/functional data
to warrant its inclusion as an additional component of
clinical stress CMR protocols.
A particularly compelling aspect of BOLD imaging
concerns its potential to elucidate the influence of local and
systemic conditions on myocardial energy utilization. Inte-
gration of BOLD with assessment of myocardial function,
structure, and tissue characteristics offers the prospect of
further expanding the multifaceted capabilities of CMR.
The current study yields important insights into potential
alterations in oxygen consumption that may occur in the
context of myocyte cell necrosis. Although perfusion-
evidenced hyperemic response was lower (p  0.0001) in
regions with hyperenhancement, oxygen consumption (as
manifested by BOLD signal intensity change) did not differ
(p  0.26). This finding may be explained by several
otential mechanisms. As posited by the investigators,
egions of viable but hibernating myocardium may down-
egulate oxygen demand in response to decreased perfusion,
aralleling reductions in energy utilizing processes such as
ontractile function. Alternatively, in the setting of non-
ransmural infarction, residual viable myocardium may be
ufficient to preserve “normal” cumulative oxygen demand as
easured on a per segment basis. Although this study did
ot examine oxygen consumption in relation to infarct
ransmurality, it is reasonable to anticipate that oxygen
onsumption would differ between regions of subendocar-
ial and transmural infarction. Beyond infarct transmurality,
xamination of serial changes in oxygen consumption and
ystolic contractility could be used to test the utility of
OLD for predicting functional response to therapeutic
nterventions such as coronary revascularization. Further
tudy is warranted to explore these issues.
Magnetic resonance imaging is a relatively new technology—
he first human body examination occurred in 1977 and took
early 5 h to produce a single image (15), In the subsequent
5 years, MRI has experienced marked technical advances
nd is now well established as a critically important tool for
ardiovascular assessment. Myocardial oxygenation imaging
olds the potential to further improve ischemia evaluation
nd yield new physiologic information. The current study by
rnold et al. (13) provides important new insights concern-ng clinical performance of state-of-the-art BOLD imaging
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May 29, 2012:1965–7 BOLD New Directions in Myocardial Ischemia Imagingand raises intriguing questions concerning the manner in
which oxygen consumption is altered in relation to changes
in myocardial perfusion, structure, and function. Further
advances in BOLD techniques are to be expected, which
should enable broader application for assessment of myo-
cardial physiology.
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